학술논문
PSY81 - Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis
Document Type
Abstract
Author
Source
In Value in Health May 2018 21 Supplement 1:S258-S258
Subject
Language
ISSN
1098-3015